Recall
FDAHealthDecember 30, 2025

Glenmark Pharmaceuticals Inc., USA — Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals In

⚠️ Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 30, 2025

Nationwide within the United States

What's affected?

Product
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
UPC
0368462157138
Lot code
19251311

Additional details

Lot #: 19251311, Exp Date April 2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 96,948 packs.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.